Degrees of Freedom of 3-user MIMO Interference Channels with Instantaneous Relay Using Interference Alignment

( Wang Qiang ),( Shu Yuquan ),( Dong Minhua ),( Xu Ji ),( Tao Xiaofeng ) 한국인터넷정보학회 2015 KSII Transactions on Internet and Information Syst Vol.9 No.5

Instantaneous relay (relay-without-delay) using interference alignment is a promising approach to neutralizing interference and improving system capacity. In Wang Chenwei`s work, a 2-user scenario required both source and relay to access the global channel state information (CSI). This paper shows a new method of interference alignment improves the degrees of freedom (DoF) prominently for the 3-user MIMO interference channel with instantaneous relay. This new method is focused on the relay node that completes the alignment interference neutralization so the global CSI is obtained only once and the pressure on the base station can be mitigated. In addition, the 3-user MIMO interference channels with instantaneous relay can achieve 2M DoF when source and destination have M antennas, respectively. This method shows 33% improvement over the conventional method using interference alignment which obtains 3M/2 DoF.

Clinicopathological Features of Low-Grade Thyroid-like Nasopharyngeal Papillary Adenocarcinoma

Minhua Li,Jiangguo Wei,Xiaofei Yao,Cheng Wang 대한암학회 2017 Cancer Research and Treatment Vol.49 No.1

Purpose Primary low-grade thyroid-like papillary adenocarcinomas are extremely rare neoplasms that generally originate in the nasopharynx. Here, we describe a novel case of a 15-year-old Chinese girl who was diagnosed with low-grade thyroid-like papillary adenocarcinoma, including a brief review of the literature to reveal the clinicopathological features of lowgrade thyroid-like nasopharyngeal papillary adenocarcinoma. Materials and Methods Immunohistochemistry was used to evaluate the expression of pan-cytokeratin (CKpan), cytokeratin (CK) 7, thyroid transcription factor 1 (TTF-1), vimentin, epithelial membrane antigen (EMA), thyroglobulin, CD15, S100, P40, CK20, CDX-2, glial fibrillary acidic protein (GFAP), and Ki-67. Additionally, in situ hybridization investigation was utilized to identify the presence of small Epstein-Barr virus (EBV)–encoded RNA. Results Histopathological analysis revealed florid proliferation of papillary structures lined by columnar epithelial cells with fibrovascular cores. Immunohistochemically, the neoplastic cells were positive for CKpan, CK7, TTF-1, vimentin, and EMA, but negative for thyroglobulin, CD15, S100, P40, CK20, CDX-2, and GFAP. The Ki-67–labeling index reached 5% in the most concentrated spot. In situ hybridization for EBV was negative. Conclusion Due to the distinct rarity of low-grade thyroid-like papillary adenocarcinomas with a favorable clinical outcome, a nationwide effort to raise public awareness of this neoplasm is required.

The Clinical Manifestation of p.Asp50Asn Heterozygous Mutation of GJB2 Gene in 3 Members of a Family Is Similar to That of Clouston Syndrome

Yanjiang Xu,Minhua Wang,Ling Huang,Jie Hu 대한피부과학회 2022 Annals of Dermatology Vol.34 No.5

Keratitis-ichthyosis-deafness (KID) syndrome has genetic heterogeneity, and the clinicalmanifestations of some patients may overlap with Clouston syndrome. A 34-year-old femalepatient came to our department with a complain of “sparse hair, rough skin, photophobiaand deafness for more than 30 years.” We found that the proband and two other familymembers (57-year-old mother and 4-year-old daughter) had similar clinical manifestations:systemic hair loss, generalized skin hyperkeratosis, especially in the metacarpophalangealarea. Subungual hyperkeratosis, finger/toenail dystrophy, as well as photophobia andepiphora. According to the investigation, one of the family members also had similar clinicalmanifestations (grandfather of the proband) and he’s died. The other three members of thefamily had no hearing impairment, and all patients had typical nail dystrophy, hair loss andpalmoplantar hyperkeratosis, similar like as seen in Clouston syndrome, so we suspected todiagnose the case as Clouston syndrome. However, after genetic testing, it was found that theproband, his mother and daughter all had p.Asp50Asn heterozygous mutations in the GJB2gene, and no mutation was detected in GJB6. The modified diagnosis was KID syndrome.

Synthesis and Characterization of 9 nm Pt–Ni Octahedra with a Record High Activity of 3.3 A/mg_Pt for the Oxygen Reduction Reaction

Choi, Sang-Il,Xie, Shuifen,Shao, Minhua,Odell, Jonathan H.,Lu, Ning,Peng, Hsin-Chieh,Protsailo, Lesia,Guerrero, Sandra,Park, Jinho,Xia, Xiaohu,Wang, Jinguo,Kim, Moon J.,Xia, Younan American Chemical Society 2013 Nano letters Vol.13 No.7

<P>Nanoscale Pt–Ni bimetallic octahedra with controlled sizes have been actively explored in recent years owning to their outstanding activity for the oxygen reduction reaction (ORR). Here we report the synthesis of uniform 9 nm Pt–Ni octahedra with the use of oleylamine and oleic acid as surfactants and W(CO)<SUB>6</SUB> as a source of CO that can promote the formation of {111} facets in the presence of Ni. Through the introduction of benzyl ether as a solvent, the coverage of both surfactants on the surface of resultant Pt–Ni octahedra was significantly reduced while the octahedral shape was still attained. By further removing the surfactants through acetic acid treatment, we observed a specific activity 51-fold higher than that of the state-of-the-art Pt/C catalyst for the ORR at 0.93 V, together with a record high mass activity of 3.3 A mg<SUB>Pt</SUB><SUP>–1</SUP> at 0.9 V (the highest mass activity reported in the literature was 1.45 A mg<SUB>Pt</SUB><SUP>–1</SUP>). Our analysis suggests that this great enhancement of ORR activity could be attributed to the presence of a clean, well-preserved (111) surface for the Pt–Ni octahedra.</P><P><B>Graphic Abstract</B> <IMG SRC='http://pubs.acs.org/appl/literatum/publisher/achs/journals/content/nalefd/2013/nalefd.2013.13.issue-7/nl401881z/production/images/medium/nl-2013-01881z_0006.gif'></P><P><A href='http://pubs.acs.org/doi/suppl/10.1021/nl401881z'>ACS Electronic Supporting Info</A></P>

Early CT Findings of Coronavirus Disease 2019 (COVID-19) in Asymptomatic Children: A Single-Center Experience

Lan Lan,Xu Dan,Xia Chen,Wang Shaokang,Yu Minhua,Xu Haibo 대한영상의학회 2020 Korean Journal of Radiology Vol.21 No.7

Objective: The current study reported a case series to illustrate the early computed tomography (CT) findings of coronavirus disease 2019 (COVID-19) in pediatric patients. Materials and Methods: All pediatric patients who were diagnosed with COVID-19 and who underwent CT scan in Zhongnan Hospital of Wuhan University from January 20, 2020 to February 28, 2020 were included in the current study. Data on clinical and CT features were collected and analyzed. Results: Four children were included in the current study. All of them were asymptomatic throughout the disease course (ranging from 7 days to 15 days), and none of them showed abnormalities in blood cell counts. Familial cluster was the main transmission pattern. Thin-section CT revealed abnormalities in three patients, and one patient did not present with any abnormal CT findings. Unilateral lung involvement was observed in two patients, and one patient showed bilateral lung involvement. In total, five small lesions were identified, including ground-glass opacity (n = 4) and consolidation (n = 1). All lesions had ill-defined margins with peripheral distribution and predilection of lower lobe. Conclusion: Small patches of ground-glass opacity with subpleural distribution and unilateral lung involvement were common findings on CT scans of pediatric patients in the early stage of the disease.

Targeting treatment of bladder cancer using PTK7 aptamer-gemcitabine conjugate

Xiang Wei,Peng Yongbo,Zeng Hongliang,Yu Chunping,Zhang Qun,Liu Biao,Liu Jiahao,Hu Xing,Wei Wensu,Deng Minhua,Wang Ning,Liu Xuewen,Xie Jianfei,Hou Weibin,Tang Jin,Long Zhi,Wang Long,Liu Jianye 한국생체재료학회 2023 생체재료학회지 Vol.27 No.00

Gemcitabine (GEM) is one of the first-line chemotherapies for bladder cancer (BC), but the GEMs cannot recognize cancer cells and have a low long-term response rate and high recurrence rate with side effects during the treatment of BC. Targeted transport of GEMs to mediate cytotoxicity to tumor and avoid the systemic side effects remains a challenge in the treatment of BC.Based on a firstly confirmed biomarker in BC-protein tyrosine kinase 7 (PTK7), which is overexpressed on the cell membrane surface in BC cells, a novel targeting system protein tyrosine kinase 7 aptamer-Gemcitabine conjugate (PTK7-GEMs) was designed and synthesized using a specific PTK7 aptamer and GEM through auto-synthesis method to deliver GEM against BC. In addition, the antitumor effects and safety evaluation of PTK7-GEMs was assessed with a series of in vitro and in vivo assays.PTK7-GEMs can specifically bind and enter to BC cells dependent on the expression levels of PTK7 and via the macropinocytosis pathway, which induced cytotoxicity after GEM cleavage from PTK7-GEMs respond to the intracellular phosphatase. Moreover, PTK7-GEMs showed stronger anti-tumor efficacy and excellent biosafety in three types of tumor xenograft mice models.These results demonstrated that PTK7-GEMs is a successful targeted aptamer-drug conjugates strategy (APDCs) to treat BC, which will provide new directions for the precision treatment of BC in the field of biomarker-oriented tumor targeted therapy.